Related Experiment Video
Updated: Jan 8, 2026

Author Spotlight: Unveiling Transmembrane Protein Family-Related Markers in Gastric Cancer and Implications for Targeted Therapies
Published on: September 15, 2023
A Multi-PTM omics atlas uncovers novel aging regulators in colorectal cancer
Yujie Zhang1, Wei Zhang2,3, Tianyuan Li1
1School of Medicine, Anhui University of Science & Technology, Huainan, 232001, China.
Background:
Aging is a key driver of colorectal cancer (CRC) progression, yet the post-translational modification (PTM) landscape associated with aging in CRC remains largely uncharacterized. In particular, the coordinated influence of multiple PTMs-such as phosphorylation, ubiquitination, and malonylation-on aging-related pathways has not been systematically explored.
Methods:
In this study, we established a CRC-specific multiomics framework by profiling phosphorylation, malonylation, and ubiquitination in matched tumor and adjacent normal tissues (n = 8 pairs). The differentially modified proteins were subjected to functional enrichment, protein-protein interaction (PPI) network construction, structural mapping, and aging pathway annotation. Key regulatory axes were reconstructed through integration of GO, KEGG, and literature-based evidence.
Results:
Aging-related PTMs were extensively dysregulated in CRC, with 162 ubiquitination sites, 64 phosphorylation sites, and 68 malonylation sites altered. LMNB1 has emerged as a multi-PTM protein, indicating coordinated control of the nuclear structure during senescence. PPI network analysis highlighted CDK1, SOD2, and MAPK1 as potential hub PTM-regulated nodes involved in the aging program of CRC. An integrated signaling model further demonstrated how PTM-mediated suppression of the EGFR-RAS axis, along with activation of the p38 and p53 pathways, collectively contributes to shaping the aging phenotype in CRC.
Conclusion:
This study presents the first integrative network map of aging regulation in CRC based on multiple PTMs. Notably, hub proteins such as LMNB1 have emerged as key regulatory targets. These findings provide a theoretical foundation for the development of aging-cancer axis-related biomarkers and therapeutic strategies for CRC.
Insights
Aging significantly impacts colorectal cancer (CRC) progression. This study reveals widespread post-translational modification (PTM) changes in aging CRC, identifying key proteins and pathways for future therapeutic targets.
Area of Science:
- Oncology
- Molecular Biology
- Aging Research
Background:
- Aging is a major factor in colorectal cancer (CRC) development.
- The role of post-translational modifications (PTMs) in aging-related CRC is not well understood.
- The combined effects of phosphorylation, ubiquitination, and malonylation on aging pathways in CRC are unexplored.
Purpose of the Study:
- To investigate the landscape of aging-related PTMs in colorectal cancer.
- To characterize the coordinated influence of multiple PTMs on aging pathways in CRC.
- To identify novel regulatory networks and potential therapeutic targets.
Main Methods:
- Established a CRC-specific multiomics framework profiling phosphorylation, malonylation, and ubiquitination.
- Analyzed differentially modified proteins using functional enrichment and protein-protein interaction (PPI) network analysis.
- Integrated pathway databases (GO, KEGG) and literature evidence to reconstruct regulatory axes.
Main Results:
- Identified extensive dysregulation of aging-related PTMs in CRC, including 162 ubiquitination, 64 phosphorylation, and 68 malonylation sites.
- LMNB1 identified as a multi-PTM protein involved in nuclear structure control during senescence.
- Highlighted CDK1, SOD2, and MAPK1 as potential PTM-regulated hub nodes in CRC aging.
- Developed a signaling model showing PTM-mediated suppression of EGFR-RAS and activation of p38/p53 pathways in CRC aging.
Conclusions:
- Presented the first integrative network map of aging regulation in CRC based on multiple PTMs.
- Identified LMNB1 as a key regulatory target in the aging-CRC axis.
- Provided a foundation for developing biomarkers and therapies targeting the aging-cancer axis in CRC.
Related Concept Videos
PI3K/mTOR/AKT Signaling Pathway
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Tumor Progression
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Cancer Stem Cells and Tumor Maintenance
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...

